Research progress on the safety of antiretroviral drugs in treatment of pregnant women with acquired immune deficiency syndrome
10.13699/j.cnki.1001-6821.2017.08.025
- VernacularTitle:抗逆转录病毒药物治疗妊娠合并艾滋病的安全性研究进展
- Author:
Lin LI
1
;
Hua HUANG
;
Jing-Jing WANG
;
Qin YAO
;
Qiao-Ling ZHENG
;
Qiong ZHOU
;
Jun ZHANG
Author Information
1. 昆明医科大学第一附属医院临床药学科
- Keywords:
antiretroviral drug;
pregnancy;
acquired immune deficiency syndrome;
mother-to-child transmission
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(8):764-767
- CountryChina
- Language:Chinese
-
Abstract:
As the first-line regimens of human immunodeficiency virus type 1 (HIV-1),antiretroviral drugs are recommended for pregnant women to prevent mother-to-child transmission.Antiretroviral drugs are an important part of the treatment of pregnant women with HIV all over the world.The safety of the three kinds of antiretroviral drugs in pregnant HIV-1-infected women are reviewed in this paper.
